PLOS Medicine, 2021
Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study

Chua W., Law J., Cardoso V. et al.

The American Journal of Cardiology, 2021
Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study)

Hussain A., Tang O., Sun C. et al.

Journal of Allergy and Clinical Immunology, 2021
Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council

Renert-Yuval Y., Thyssen J., Bissonnette R. et al.

The Journal of Infectious Diseases, 2021
Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C

Khera T., Du Y., Todt D. et al.

Journal of Clinical Investigation, 2021
Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity

Falck-Jones S., Vangeti S., Yu M. et al.

Scientific Reports, 2021
Blood-based protein profiling identifies serum protein c-KIT as a novel biomarker for hypertrophic cardiomyopathy

Sonnenschein K., Fiedler J., de Gonzalo-Calvo D. et al.

Scientific Reports, 2021
Differential effects on blood and cerebrospinal fluid immune protein markers and kynurenine pathway metabolites from aerobic physical exercise in healthy subjects

Isung J., Granqvist M., Trepci A. et al.

Cancer Cell, 2021
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients

Remsik J., Wilcox J., Babady N. et al.

Clinical Infectious Diseases, 2021
Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease

Stanley T., Fourman L., Wong L. et al.

PLOS Medicine, 2021
Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study

Wallentin L., Eriksson N., Olszowka M. et al.

ESC Heart Failure, 2021
Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension

Arvidsson M., Ahmed A., Bouzina H. et al.

Metabolites, 2020
Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)

Chorell E., Olsson T., Jansson J. et al.

Journal of Autoimmunity, 2020
Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis

Buitrago-Molina L., Pietrek J., Noyan F. et al.

United European Gastroenterology Journal, 2020
Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients

Owusu Sekyere S., Port K., Deterding K. et al.

European Journal of Heart Failure, 2020
Is acute heart failure a distinctive disorder? An analysis from BIOSTAT‐CHF

Davison B., Senger S., Sama I. et al.

Brain Communications, 2020
Toll-like receptor linked cytokine profiles in cerebrospinal fluid discriminate neurological infection from sterile inflammation

Cuff S., Merola J., Twohig J. et al.

Cardiovascular Diabetology, 2020
Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events

Singh P., Goncalves I., Tengryd C. et al.

Translational Vision Science & Technology, 2020
Cluster Analysis of Early Postnatal Biochemical Markers May Predict Development of Retinopathy of Prematurity

Markasz L., Olsson K., Holmström G. et al.

British Journal of Cancer, 2020
Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer

Liu S., Shen M., Hsu E. et al.

Scientific Reports, 2020
Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19

Haljasmägi L., Salumets A., Rumm A. et al.